Exome Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,178
| Closed | -$1.56M | – | 76 |
|
|
2024
Q4 | $1.56M | Sell |
28,178
-17,422
| -38% | -$965K | 1.17% | 34 |
|
|
2024
Q3 | $1.5M | Buy |
+45,600
| New | +$1.5M | 1.01% | 43 |
|
|
2024
Q2 | – | Sell |
-66,300
| Closed | -$2.41M | – | 72 |
|
|
2024
Q1 | $2.41M | Sell |
66,300
-18,100
| -21% | -$658K | 2.06% | 18 |
|
|
2023
Q4 | $1.71M | Buy |
+84,400
| New | +$1.71M | 1.69% | 26 |
|